Thursday, October 25
How to Secure Coverage and Reimbursement for New Technologies,
Track: Adding Value to Your Lab
Thursday, October 25
2:30 pm - 3:20 pm
Regency D


  • Greg Richard (Speaker) Chief Commercial Officer, Interpace Diagnostics


The bar for providing evidence to secure coverage and reimbursement for new technologies is routinely being raised. As an example, laboratories can meet the evidence requirements of Evidence Street and still not meet those of Anthem BCBS, another BCBS Association member. The varying definitions of clinical utility among health plans and third party technology assessment providers require lab companies to conduct numerous studies and publish data in multiple peer reviewed publications with little to no assurance that they will successfully secure coverage. Further, this lack of coverage often results in challenges with physician adoption due to the financial burden placed on patients in the absence of coverage for high cost, molecular testing and the continuing increase in patients’ responsibilities associated with benefit plan design. This talk will provide suggestions to address these challenges for participating laboratory providers.

  • Learner will be able to negotiate with Medicare and/or Commercial payers for coverage of molecular products/testing services
  • Learner will be able to develop a dossier and effective submission to third party technology assessment organizations
  • Learner will be able to respond to RFP’s or other requests for information required to secure coverage

Add to my calendar

Add to Google Add to Outlook (.ics)

Create your personal schedule through the official app, Whova!

Get Started